Mercury Medical®, the primary US distributor of Medovate’s SAFIRA™ (SAFer Injection for Regional Anesthesia) will join the two companies in highlighting the importance of using ultrasound-guidance with SAFIRA™ to improve patient safety and clinical efficiency during regional anaesthesia procedures.
Medovate Forms Partnership with Konica Minolta Healthcare Americas to Promote Best Practice in Regional Anesthesia
The partnership will highlight the provision of Ultrasound-Guided Regional Anesthesia and how the revolutionary SAFIRA™ can be used in conjunction with Konica Minolta Healthcare Americas’ range of pioneering ultrasound solutions.
Mercury Medical has positioned itself as a US leader in providing technological advances for clinicians in both airway solutions and anesthesia, a philosophy that aligns with Medovate and SAFIRA™.
SAFIRA, developed in collaboration with UK National Health Service (NHS) clinicians, transforms the technique of Peripheral Nerve Blockade into a one-person procedure, giving the anesthetist full control of the injection at all times.
SAFIRA ® is a revolutionary new technology that transforms regional anesthesia into a one-person procedure, putting control in the hands of the anesthetist.